Ensysce Biosciences Inc
NASDAQ:ENSC

Watchlist Manager
Ensysce Biosciences Inc Logo
Ensysce Biosciences Inc
NASDAQ:ENSC
Watchlist
Price: 1.12 USD -5.08% Market Closed
Market Cap: 4m USD

Wall Street
Price Targets

ENSC Price Targets Summary
Ensysce Biosciences Inc

There are no price targets for ENSC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ensysce Biosciences Inc Competitors:
Price Targets
PYXS
Pyxis Oncology Inc
520% Upside
RCUS
Arcus Biosciences Inc
42% Upside
CRSP
CRISPR Therapeutics AG
41% Upside
SCLP
Scancell Holdings PLC
224% Upside
9926
Akeso Inc
54% Upside
NTLA
Intellia Therapeutics Inc
131% Upside
PRQR
ProQR Therapeutics NV
350% Upside
2157
Lepu Biopharma Co Ltd
106% Upside

Revenue
Forecast

Revenue Estimate
Ensysce Biosciences Inc

The compound annual growth rate of Ensysce Biosciences Inc's revenue for the next 3 years is 158%.

N/A
Past Growth
158%
Estimated Growth
Estimates Accuracy
14%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Ensysce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Ensysce Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-98%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ENSC's stock price target?
Not Available

ENSC doesn't have any price targets made by Wall Street professionals.

What is Ensysce Biosciences Inc's Revenue forecast?
Projected CAGR
158%

The compound annual growth rate of Ensysce Biosciences Inc's revenue for the next 3 years is 158%.

Back to Top